CONMED Corp — Director's Dealing 2024

Sep 9, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2024-09-05

Reporting Person: Farkas Charles (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-09-05	Common Stock	M	1000	$39.64	Acquired	20880	Direct
2024-09-05	Common Stock	F	534	$74.31	Disposed	20346	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-05	SARs (Stock Appreciation Rights)	$39.64	M	1000	Disposed	2024-09-11	Common Stock (1000)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs vesting on June 1, 2015 and expiring on September 11, 2024.